title: Drug-resistant tuberculosis: what is to be done?
authors: Dr. Schluger is Chief, Division of Pulmonary, Allergy, and Critical Care Medicine, Professor of Medicine, Epidemiology and Environmental Health Sciences, Columbia University College of Physicians and Surgeons, New York, NY. Electronic address: ns311@columbia.edu.
authors: Neil W
authors: NW
authors: Schluger
mesh_terms: D000995:Antitubercular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D003140:Communicable Disease Control / Q000379:methods*; D024881:Drug Resistance, Bacterial; D005260:Female; D014943:Global Health; D006801:Humans; D015994:Incidence; D008297:Male; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D020380:Needs Assessment; D018570:Risk Assessment; D015996:Survival Rate; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology*
chemical_list: D000995:Antitubercular Agents